D Peckham, A Watson, K Pollard, C Etherington, S.P Conway

Slides:

Advertisements

Similar presentations

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Advertisements

How surgeons can find information online? Martin Hewitt International Journal of Surgery Volume 5, Issue 6, Pages (December 2007) DOI: /j.ijsu

Long-term non-invasive ventilation in cystic fibrosis — Experience over two decades William G. Flight, Jonathan Shaw, Susan Johnson, A. Kevin Webb, Andrew.

Use of the insulin pump in treat cystic fibrosis related diabetes Dana S. Hardin, Julie Rice, Mark Rice, Randall Rosenblatt Journal of Cystic Fibrosis.

Volume 46, Issue 3, Pages (March 2007)

ARFI and transient elastography for characterization of cystic fibrosis related liver disease: First longitudinal follow-up data in adult patients Thomas.

Cheryl Cameron, Mark W. Lodes, William M. Gershan

Effects of ivacaftor on severely ill patients with cystic fibrosis carrying a G551D mutation Helge Hebestreit, Annette Sauer-Heilborn, Rainald Fischer,

The prevalence of “risky behaviour” in adults with cystic fibrosis

Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation Kris De Boeck, Anne Munck, Seth Walker, Albert Faro,

P. Whitaker, N. Shaw, J. Gooi, C. Etherington, S. Conway, D. Peckham

The immediate effect of musculoskeletal physiotherapy techniques and massage on pain and ease of breathing in adults with cystic fibrosis Annemarie Lee,

Development, validation, and implementation of a questionnaire assessing disease knowledge and understanding in adult cystic fibrosis patients Karen.

William G. Flight, Jonathan Shaw, Susan Johnson, A

ARFI and transient elastography for characterization of cystic fibrosis related liver disease: First longitudinal follow-up data in adult patients Thomas.

How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF? Sarah P. Cohen, David M. Orenstein

H. Grasemann, E. Tullis, F. Ratjen Journal of Cystic Fibrosis

Megan R. Nelson, Craig R. Adamski, Audrey Tluczek

Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study Doug L. Forrester, Alan J. Knox,

Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation Kris De Boeck, Anne Munck, Seth Walker, Albert Faro,

Ludger Dorlöchter, Malin Carlsson, Edda J. Olafsdottir, Ola D

Laura Viviani, Baroukh M. Assael, Eitan Kerem

Cirrhosis and other liver disease in cystic fibrosis

John Widger, Sarath Ranganathan, Philip J. Robinson

The ease of breathing test tracks clinical changes in cystic fibrosis

Controlled clinical trials in cystic fibrosis — are we doing better?

Feasibility of using pedometers to measure daily step counts in cystic fibrosis and an assessment of its responsiveness to changes in health state Bradley.

Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar

Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox

The predictive potential of the sweat chloride test in cystic fibrosis patients with the G551D mutation Verena I. Seliger, David Rodman, Fredrick Van.

Hypertonic saline and recombinant human DNase: a randomised cross-over pilot study in patients with cystic fibrosis Manfred Ballmann, Horst von der Hardt

A.H. Gifford Journal of Cystic Fibrosis

Treatment of resistant distal intestinal obstruction syndrome with a modified antegrade continence enema procedure I.J. Clifton, A.M. Morton, N.S. Ambrose,

Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009 Yolanda P. Lillquist,

Cystic fibrosis related diabetes in an extremely young patient

Predicting hypoxia in cystic fibrosis patients during exposure to high altitudes Wolfgang Kamin, Birthe Fleck, Dirk-Mathias Rose, Oliver Thews, Wolfgang.

Antonia V. Bennett, Donald L. Patrick, James F. Lymp, Todd C

Molecular analysis of changes in Pseudomonas aeruginosa load during treatment of a pulmonary exacerbation in cystic fibrosis D.W. Reid, R. Latham, I.L.

Correlation of sweat chloride and percent predicted FEV1 in cystic fibrosis patients treated with ivacaftor Meredith C. Fidler, Jack Beusmans, Paul Panorchan,

Different opinions of physicians on the importance of measures to prevent acquisition of Pseudomonas aeruginosa from the environment Gratiana Steinkamp,

Depression and anxiety in adolescents and adults with cystic fibrosis in the UK: A cross- sectional study Alistair J.A. Duff, Janice Abbott, Carolyn Cowperthwaite,

Ultrasound and magnetic resonance imaging assessment of joint disease in symptomatic patients with cystic fibrosis arthropathy G. Fitch, K. Williams,

Anastasios Lekkas, Khin M. Gyi, Margaret E. Hodson

Narelle S. Cox, Jennifer Follett, Karen O. McKay

Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis Geraint B. Rogers, Lucas R. Hoffman,

Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation: Safety and efficacy in an expanded access program in the United.

Nutritional decline in cystic fibrosis related diabetes: The effect of intensive nutritional intervention H. White, K. Pollard, C. Etherington, I. Clifton,

Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005 F.A. Millar, N.J. Simmonds, M.E. Hodson Journal.

F. Vermeulen, P. Lebecque, K. De Boeck, T. Leal

Lung clearance index during hospital admission in school-age children with cystic fibrosis Liam Welsh, Christopher Nesci, Haily Tran, Marisol Tomai,

H. White, A.M. Morton, S.P. Conway, D.G. Peckham

J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer

Reviewer Acknowledgment

Bigna M. Keller, Carmen Casaulta Aebischer, Richard Kraemer, Martin H

Serum-surfactant SP-D correlates inversely to lung function in cystic fibrosis Hanne Vebert Olesen, Uffe Holmskov, Peter Oluf Schiøtz, Grith Lykke Sørensen

D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher

Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study E.M. Westerman, P.P.H.

Experience using centralized spirometry in the phase 2 randomized, placebo-controlled, double-blind trial of denufosol in patients with mild to moderate.

The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation C. Etherington,

‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis

Beta-lactam allergy in adults with cystic fibrosis

Predictors of non-referral of patients with cystic fibrosisfor lung transplant evaluation in the United States Kathleen J. Ramos, Bradley S. Quon, Kevin.

Cheryl Cameron, Mark W. Lodes, William M. Gershan

Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz Journal of Cystic Fibrosis

Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub

David Adeboyeku, Sandra Scott, Margaret E. Hodson

A safe protocol for rapid desensitization in patients with cystic fibrosis and antibiotic hypersensitivity Henry J. Legere, Ross I. Palis, Tito Rodriguez.

Population pharmacokinetics of tobramycin administered thrice daily and once daily in children and adults with cystic fibrosis D.J. Touw, A.J. Knox,

Cystic fibrosis and pregnancy in the modern era: A case control study

H. White, A.M. Morton, D.G. Peckham, S.P. Conway

Presentation transcript:

Predictors of desaturation during formal hypoxic challenge in adult patients with cystic fibrosis D Peckham, A Watson, K Pollard, C Etherington, S.P Conway Journal of Cystic Fibrosis Volume 1, Issue 4, Pages 281-286 (December 2002) DOI: 10.1016/S1569-1993(02)00100-5

Fig. 1 This figure demonstrates the distribution of FEV1 according to the various subgroups of the PaO2 taken at the end of a formal pre-flight hypoxic challenge. Journal of Cystic Fibrosis 2002 1, 281-286DOI: (10.1016/S1569-1993(02)00100-5)

Fig. 2 Comparison between baseline PaO2 and level of hypoxia following in flight assessment. Journal of Cystic Fibrosis 2002 1, 281-286DOI: (10.1016/S1569-1993(02)00100-5)

Fig. 3 This figure demonstrates the distribution of the N score according to the various subgroups of the PaO2 (kPa) taken at the end of a formal pre-flight hypoxic challenge. Journal of Cystic Fibrosis 2002 1, 281-286DOI: (10.1016/S1569-1993(02)00100-5)